| Latest Glaxosmithkline News Headlines |
| Date | Time | Source | |
| 10/20/2009 | 9:16AM | PRNUS | Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak
PRINCETON, N.J., Oct. 20 /PRNewswire/ -- Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for GlaxoSmithKline (NYSE:GSK), Sanofi-Aventis... More...>> |
| 10/08/2009 | 3:55PM | PRNUS | GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations
PHILADELPHIA, Oct. 8 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham... More...>> |
| 09/21/2009 | 9:04AM | PRNUS | GSK Limits Medical Education Funding to Independent Programs With Highest Impact on Patient Care
RESEARCH TRIANGLE PARK, N.C., Sept. 21 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) today announced new standards for funding accredited, continuing medical education (CME) for healthcare professionals to ensure the programs result in improved patient health. Starting in 2010, GSK will raise the bar and fund... More...>> |
| 09/16/2009 | 10:00AM | PRNUS | GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines
RESEARCH TRIANGLE PARK, N.C., Sept. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) today announced that it is making free medicines easier to obtain for patients who are unemployed, uninsured or struggling to make ends meet.
GSK is improving access to its patient assistance program, Bridges to Access, by offering... More...>> |
| 08/27/2009 | 9:33AM | PRNUS | Tennis Legend John McEnroe Tells Men to 'Get Serious' About Prostate Cancer
Teaming With Health Organizations To Make Men Aware of New Guidelines: Talk With Doctor About Prostate Cancer At Age 40
PHILADELPHIA, Aug. 27 /PRNewswire-FirstCall/ -- Seven-time grand slam winner John McEnroe, whose father was diagnosed with prostate cancer in 2006, is providing his voice and image to a new campaign... More...>> |
| 08/24/2009 | 4:30PM | PRNUS | GSK Advisory: Warehouse Theft
RESEARCH TRIANGLE PARK, N.C., Aug. 24 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) is advising that two lots of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) medication were stolen on August 2 from the company's distribution facility near Richmond, Virginia. Medicine in the stolen... More...>> |
| 08/19/2009 | 8:13PM | PRNUS | Video: FDA Approves GSK's Hib Vaccine, Hiberix(R)
Hiberix available for millions of children who need a booster dose against potentially fatal infection
PHILADELPHIA, Aug. 19 /PRNewswire-FirstCall/ -- In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE:GSK) has received accelerated approval from... More...>> |
| 07/22/2009 | 11:23AM | PRNUS | GlaxoSmithKline Completes Acquisition of Stiefel
- GSK creates new world-leading specialist dermatology business with revenues of approximately $1.5 billion - Significant step forward to diversify GSK's business and provide immediate new growth opportunities
RESEARCH TRIANGLE PARK, N.C., July 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (GSK) (NYSE:GSK) today announced... More...>> |
| 07/16/2009 | 4:38PM | PRNUS | GSK to Announce Q2 Results July 22, 2009
PHILADELPHIA, July 16 /PRNewswire-FirstCall/ -- On Wednesday, July 22nd, GlaxoSmithKline plc (NYSE:GSK) will announce its second quarter financial results for the three months ended June 30, 2009. It is anticipated that the announcement will be released to the London Stock Exchange at approximately 7:00 AM EDT.
Following... More...>> |
| 06/03/2009 | 1:28PM | PRNUS | GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
TBWA assigned alli and Smoking Control
PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline Consumer Healthcare (GSK Consumer Healthcare) (NYSE:GSK) has announced advertising agency changes to support growth for global brands. The changes will see GSK Consumer Healthcare partnering with agencies that have comparable... More...>> |
| 06/01/2009 | 8:00AM | PRNUS | FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
RESEARCH TRIANGLE PARK, N.C., June 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) announced today that the U.S. Food and Drug Administration has approved Lamictal(R)XR(TM) (lamotrigine) Extended-Release Tablets as once-a-day add-on therapy for epilepsy patients 13 years of age or older with partial onset seizures... More...>> |
| 05/11/2009 | 7:00AM | PRNUS | FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
- Easy-to-swallow formulation provides important new alternative for patients
RESEARCH TRIANGLE PARK, N.C., May 11 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved Lamictal(R) ODT(TM) (lamotrigine) Orally Disintegrating Tablets. Lamictal... More...>> |
| 05/06/2009 | 6:00AM | PRNUS | GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it has entered into an agreement to divest full commercial rights to Wellbutrin XL(R) in the United States to Biovail International Laboratories SRL, a subsidiary of Biovail Corporation (NYSE, TSX: BVF... More...>> |
| 05/05/2009 | 8:30AM | PRNUS | ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist
Development Candidate Triggers Milestone Payment from GlaxoSmithKline
MOUNTAIN VIEW, Calif., May 5 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it has identified an orally bioavailable small molecule antagonist of the C5a receptor, CCX168, as a candidate for clinical development. The acceptance of the molecule... More...>> |
| 05/01/2009 | 3:46PM | PRNUS | GlaxoSmithKline Update: Influenza A (H1N1)
LONDON and RESEARCH TRIANGLE PARK, N.C., May 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) is committed to supporting governments and health authorities around the world to respond to the emergence of the new influenza A (H1N1) strain.
The company has developed a number of potential interventions which it... More...>> |
| 05/01/2009 | 2:23PM | PRNUS | GlaxoSmithKline Update: Influenza A (H1N1)
LONDON and RESEARCH TRIANGLE PARK, N.C., May 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) is committed to supporting governments and health authorities around the world to respond to the emergence of the new influenza A (H1N1) strain.
The company has developed a number of potential interventions which it... More...>> |
| 04/21/2009 | 1:22PM | PRNUS | GSK Notice of First Quarter 2009 Financial Results Announcement and Teleconference
PHILADELPHIA, April 21 /PRNewswire-FirstCall/ -- On Wednesday, April 22, 2009 GlaxoSmithKline plc (NYSE:GSK) will announce its first quarter financial results for the three months ended March 31, 2009. It is anticipated that the announcement will be released to the London Stock Exchange at approximately 7:00 AM EDT.
At... More...>> |
| 04/20/2009 | 7:00AM | PRNUS | GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
Stiefel, the world's largest independent dermatology company, acquired by GSK in deal valued at up to $3.6 billion
LONDON, April 20 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) and Stiefel Laboratories Inc. today announced that they have signed an agreement to create a new world-leading specialist dermatology... More...>> |
| 04/16/2009 | 1:54PM | PRNUS | Beacon Equity Issues Trade Alerts on Thursday's Newsworthy Market Movers
DALLAS, April 16 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.
Investors can view all of the daily trade alerts for free by visiting BeaconEquity.com/m.
Today's Trade Alerts include: Southwest Airlines Co. (NYSE:LUV), Nokia Corp. (NYSE:NOK), Gannett Co. (NYSE:GCI... More...>> |
| 04/01/2009 | 9:00AM | PRNUS | GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US
GlaxoSmithKline (NYSE:GSK) today announced the submission of two simultaneous regulatory applications to expand the use of TYVERB(R)/TYKERB(R) (lapatinib). If approved, TYVERB(R)/TYKERB(R) could be used as a first-line therapy regimen combined with anti-hormonal therapy for patients with hormone-sensitive, metastatic... More...>> |